ArticleCancer reports (Hoboken, N.J.)2025

Prognostic Impact of Clostridium butyricum MIYAIRI (CBM588) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study.

Junya Arima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.